Insights

Gene Therapy Partnerships Sangamo Therapeutics has been actively forming partnerships with companies like Astellas, Genentech, and FDA for gene therapy development, indicating potential collaboration and sales opportunities in the biotechnology sector.

Financial Investment Receiving a significant upfront financing of $50M from Roche's Genentech demonstrates financial stability and potential for further investment opportunities, showcasing trust in Sangamo Therapeutics' research and development capabilities.

Market Expansion Continued expansion into the development of intravenously-administered genomic medicines for neurodegenerative diseases highlights market growth and potential sales opportunities in the healthcare industry, especially with the success of previous deals.

Research Innovation Being at the forefront of in vivo human genome editing studies and engaging in productive discussions with regulatory bodies like the FDA showcases research innovation, creating opportunities for sales of groundbreaking therapies in the future.

Competitive Positioning Sangamo Therapeutics' revenue range of $50M - 100M places it among similar companies like Editas Medicine and Verve Therapeutics, positioning it favorably in the market and indicating room for further growth and competitive sales strategies.

Sangamo Therapeutics, Inc. Tech Stack

Sangamo Therapeutics, Inc. uses 8 technology products and services including OneTrust, Microsoft Outlook, Backbone.js, and more. Explore Sangamo Therapeutics, Inc.'s tech stack below.

  • OneTrust
    Cookie Compliance
  • Microsoft Outlook
    Email
  • Backbone.js
    Javascript Frameworks
  • Microsoft
    Miscellaneous
  • Amazon Web Services
    Platform As A Service
  • Yoast SEO
    Search Engines
  • X-XSS-Protection
    Security
  • Bootstrap
    UI Frameworks

Media & News

Sangamo Therapeutics, Inc.'s Email Address Formats

Sangamo Therapeutics, Inc. uses at least 1 format(s):
Sangamo Therapeutics, Inc. Email FormatsExamplePercentage
FLast@sangamo.comJDoe@sangamo.com
96%
LastFi@sangamo.comDoeJo@sangamo.com
2%
FMiddleLast@sangamo.comJMichaelDoe@sangamo.com
1%
First@sangamo.comJohn@sangamo.com
1%

Frequently Asked Questions

Where is Sangamo Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Sangamo Therapeutics, Inc.'s main headquarters is located at 7000 Marina Blvd Brisbane, California 94005 US. The company has employees across 6 continents, including North AmericaEuropeAsia.

What is Sangamo Therapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Sangamo Therapeutics, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Sangamo Therapeutics, Inc.'s stock symbol?

Minus sign iconPlus sign icon
Sangamo Therapeutics, Inc. is a publicly traded company; the company's stock symbol is SGMO.

What is Sangamo Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Sangamo Therapeutics, Inc.'s official website is sangamo.com and has social profiles on LinkedIn.

How much revenue does Sangamo Therapeutics, Inc. generate?

Minus sign iconPlus sign icon
As of January 2025, Sangamo Therapeutics, Inc.'s annual revenue reached $75M.

What is Sangamo Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Sangamo Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Sangamo Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of January 2025, Sangamo Therapeutics, Inc. has approximately 289 employees across 6 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: S. M.Chief Executive Officer And President: A. M.Chief Financial Officer: P. D.. Explore Sangamo Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Sangamo Therapeutics, Inc. belong to?

Minus sign iconPlus sign icon
Sangamo Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Sangamo Therapeutics, Inc. use?

Minus sign iconPlus sign icon
Sangamo Therapeutics, Inc.'s tech stack includes OneTrustMicrosoft OutlookBackbone.jsMicrosoftAmazon Web ServicesYoast SEOX-XSS-ProtectionBootstrap.

What is Sangamo Therapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
Sangamo Therapeutics, Inc.'s email format typically follows the pattern of . Find more Sangamo Therapeutics, Inc. email formats with LeadIQ.

How much funding has Sangamo Therapeutics, Inc. raised to date?

Minus sign iconPlus sign icon
As of January 2025, Sangamo Therapeutics, Inc. has raised $24M in funding. The last funding round occurred on Mar 22, 2024 for $24M.

When was Sangamo Therapeutics, Inc. founded?

Minus sign iconPlus sign icon
Sangamo Therapeutics, Inc. was founded in 1995.
Sangamo Therapeutics, Inc.

Sangamo Therapeutics, Inc.

Biotechnology ResearchCalifornia, United States201-500 Employees

For Sangamo Therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. Our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. Currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. To learn more about Sangamo, visit the our website at www.sangamo.com.

Section iconCompany Overview

Headquarters
7000 Marina Blvd Brisbane, California 94005 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
SGMO
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1995
Employees
201-500

Section iconFunding & Financials

  • $24M

    Sangamo Therapeutics, Inc. has raised a total of $24M of funding over 7 rounds. Their latest funding round was raised on Mar 22, 2024 in the amount of $24M.

  • $50M$100M

    Sangamo Therapeutics, Inc.'s revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $24M

    Sangamo Therapeutics, Inc. has raised a total of $24M of funding over 7 rounds. Their latest funding round was raised on Mar 22, 2024 in the amount of $24M.

  • $50M$100M

    Sangamo Therapeutics, Inc.'s revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.